Synthesis and evaluation of the acetylcholinesterase inhibitory effect of novel aromatic derivatives bearing a 2-(5-(pyridin-2- yl)-2H-tetrazol-2-yl)alkyl scaffold

Acetylcholinesterase (AChE) is a key therapeutic target for developing new Alzheimer's disease (AD) treatments due to its regulatory function in acetylcholine hydrolysis. This research contributed to the development of a novel scaffold for AChE inhibitors, which are potential drugs for treating AD.